Do "screening" coagulation tests predict bleeding in patients undergoing fiberoptic bronchoscopy with biopsy?

Area of Science:

• Pulmonology
• Gastroenterology
• Internal Medicine

Background:

• Flexible fiberoptic bronchoscopy (FOB) with biopsy is a common procedure.
• Bleeding is a potential complication of FOB with biopsy.
• Predicting bleeding risk is crucial for patient safety.

Purpose of the Study:

• To evaluate the utility of preprocedure coagulation testing in predicting bleeding after FOB with biopsy.
• To identify clinical predictors of bleeding in patients undergoing FOB with biopsy.

Main Methods:

• Retrospective chart review of 274 patients undergoing 305 FOB with biopsy procedures.
• Analysis of clinical predictors, prebronchoscopy laboratory abnormalities, and bleeding complications.

Main Results:

• Thirty-five patients experienced bleeding complications.
• Only 3 patients with bleeding had abnormal coagulation studies.
• 68% of bleeding patients had normal coagulation results and no clinical risk factors.

Conclusions:

• Preprocedure coagulation testing does not reliably predict bleeding risk in patients undergoing FOB with biopsy.
• Routine coagulation testing is not beneficial for patients undergoing FOB with biopsy.
• Clinical risk factors alone are insufficient to predict bleeding post-FOB.